LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $3,843,000 | +23.1% | 14,000 | -7.1% | 0.57% | +16.1% |
Q2 2018 | $3,121,000 | -10.1% | 15,066 | -28.3% | 0.49% | -14.9% |
Q1 2018 | $3,471,000 | +83.4% | 21,017 | -4.9% | 0.58% | +92.7% |
Q3 2015 | $1,893,000 | -31.1% | 22,100 | -18.9% | 0.30% | -6.8% |
Q2 2015 | $2,748,000 | -21.4% | 27,236 | -40.0% | 0.32% | -20.3% |
Q1 2015 | $3,498,000 | +225.4% | 45,367 | +162.8% | 0.40% | +98.0% |
Q2 2014 | $1,075,000 | -37.7% | 17,264 | -32.7% | 0.20% | -34.4% |
Q1 2014 | $1,725,000 | +11.7% | 25,654 | -12.6% | 0.31% | +12.7% |
Q4 2013 | $1,544,000 | +21.4% | 29,362 | -0.1% | 0.28% | +8.7% |
Q3 2013 | $1,272,000 | -57.1% | 29,397 | -62.9% | 0.25% | -60.6% |
Q2 2013 | $2,967,000 | – | 79,291 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |